Bone Biologics (BBLG) Long-Term Debt Repayments (2014 - 2021)

Bone Biologics (BBLG) reported Long-Term Debt Repayments of $10609.0 for Q1 2021, down 96.73% quarter-over-quarter from $324188.0 in Q4 2014.

Bone Biologics (BBLG) Long-Term Debt Repayments (2014 - 2021) Analysis & Trends

Bone Biologics (BBLG) has 2 years of Long-Term Debt Repayments data on file, last reported at $10609.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	-21,671.00
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-
9	Abivax	95.45 Bn	95.45 Bn	-	-
10	Bone Biologics	1.47 Mn	1.47 Mn	-	-

Download Data